Funded Research

• Giant Cell Myocarditis Treatment Trial
  Principal Investigator: L. Cooper, MD
  NIH/Governmental Funding
• Genetic Modulation of Left Ventricular Recovery
  Principal Investigator: D. McNamara, MD
  NIH/Governmental Funding
• Vascular Medicine Clinical Research Training Program
  Principal Investigator: J. Heit, MD; Coordinating Investigator: L.Cooper, MD
  NIH/Governmental Funding
• Role of TEH Co-stimulator Molecular Slam
  Principal Investigator: William A. Faubion, MD
  NIH/Governmental Funding
• Role of Vitamin D in Dendritic Cell Immune Functions
  Principal Investigator: Matthew D. Griffin, MD
  NIH/Governmental Funding
• Roles of Dendritic Cells in Rena Immune Responses
  Principal Investigator: Matthew D. Griffin, MD
  NIH/Governmental Funding
• Mechanisms of Eosinophil Degranulation in Human Disease
  Principal Investigator: Hirohito Kita, MD
  NIH/Governmental Funding
• Mechanisms of Eosinophilic Inflammation in Human Asthma
  Principal Investigator: Hirohito Kita, MD
  NIH/Governmental Funding
• Modulation of Human Eosinophil Survival
  Principal Investigator: Hirohito Kita, MD
  Industry Funding
• Pathogenesis of Chronic Rhinosinusitis
  Principal Investigator: Hirohito Kita, MD
  NIH/Governmental Funding
• Autoimmunity Targeting Water Channels
  Principal Investigator: Vanda Lennon, MD, PhD
  Industry Funding
• Pathobiology of the Enteric Nervous System: Project #2 Leader: Autoimmune and Diabetic Dysmotility
  Principal Investigator: Vanda Lennon, MD, PhD
  NIH/Governmental Funding
• Spectrum of Autoimmune Gastrointestinal Dysmotility
  Principal Investigator: Vanda Lennon, MD, PhD
  NIH/Governmental Funding
• Genetic Polymorphisms in Rheumatoid Arthritis
  Principal Investigator: Eric L. Matteson, MD
  NIH/Governmental Funding
• Phase 2, Multi-center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Safety, Tolerability and Efficacy of Lymphostat-B Antibody in Subjects with Rheumatoid Arthritis
  Principal Investigator: Eric L. Matteson, MD
  Industry Funding
• Randomized Double-Masked, Placebo-Controlled, Multi-center Study of the Safety and Efficacy of Infliximab in Subjects with Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Anti-TNFS Therapies
  Principal Investigator: Eric L. Matteson, MD
  Industry Funding
• Randomized Double-Masked, Placebo-Controlled, Multi-center Study of the Safety and Efficacy of Infliximab in Subjects with Giant Cell Arteritis
  Principal Investigator: Eric L. Matteson, MD
  Industry Funding
• Support of Educational Activities for Current Fellow in Training
  Principal Investigator: Eric L. Matteson, MD
  Industry Funding
• Support for Training of Rheumatology Fellow
  Principal Investigator: Eric L. Matteson, MD
  Industry Funding
• Celiac Disease Studies
  Principal Investigator: Joseph A. Murray, MD
  Industry Funding
• Epidemiology of Celiac Disease: A Population-based Study
  Principal Investigator: Joseph A. Murray, MD
  NIH/Governmental Funding
• APPLE Study: Prevention of Cardiovascular Complications of Pediatric Systemic Lupus Erythematosus: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
  Principal Investigator: Ann M. Reed, MD
  NIH/Governmental Funding
• Genetic Effect on Breaking Tolerance
  Principal Investigator: Ann M. Reed, MD
  Foundation Funding
• HLA Genetics and Chimerism in Juvenile Dermatomyositis
  Principal Investigator: Ann M. Reed, MD
  Foundation Funding
• Alterations in Dendritic Cell-Mediated Immunity Caused by Smoking
  Principal Investigator: Robert Vassallo, MD
  Foundation Funding
• Role of TSLP in the Pathogenesis of Pulmonary LCH
  Principal Investigator: Robert Vassallo, MD
  Foundation Funding